Enzo Biochem, Inc.
ENZ
Price:
$0.97
Market Cap:
$50.68M
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. The Life Sciences Products segment develops, manufactures, and markets products and tools to clinical research, drug development, and bioscience research customers. It offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysi...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
1980-06-12
Stock Exchange
NYSE
Ticker
ENZ
PE Ratio
[-5.11]
ROE
[-38.61%]
Current Ratio
[2.82]
Dividend Yield
[10.31%]
Enterprise Value
[1.81M]
Dividend History
The ROE as of November 2024 (TTM) for Enzo Biochem, Inc. (ENZ) is -38.61%
According to Enzo Biochem, Inc.’s latest financial reports and current stock price. The company's current ROE is -38.61%. This represents a change of 272.52% compared to the average of -10.36% of the last 4 quarters.
Enzo Biochem, Inc. (ENZ) Historical ROE (quarterly & annually)
How has ENZ ROE performed in the past?
The mean historical ROE of Enzo Biochem, Inc. over the last ten years is -20.03%. The current -38.61% ROE has changed 92.75% with respect to the historical average. Over the past ten years (40 quarters), ENZ's ROE was at its highest in in the July 2023 quarter at 73.19%. The ROE was at its lowest in in the April 2023 quarter at -77.82%.
Average
-20.03%
Median
-9.04%
Minimum
-114.82%
Maximum
50.57%
Enzo Biochem, Inc. (ENZ) ROE by Quarter and Year
Discovering the peaks and valleys of Enzo Biochem, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 802.50%
Maximum Annual ROE = 50.57%
Minimum Annual Increase = -1042.90%
Minimum Annual ROE = -114.82%
| Year | ROE | Change |
|---|---|---|
| 2024 | -46.47% | -279.74% |
| 2023 | 25.86% | -162.37% |
| 2022 | -41.46% | -930.17% |
| 2021 | 4.99% | -108.60% |
| 2020 | -58.05% | -49.44% |
| 2019 | -114.82% | 802.50% |
| 2018 | -12.72% | 351.56% |
| 2017 | -2.82% | -105.57% |
| 2016 | 50.57% | -1042.90% |
| 2015 | -5.36% | -80.14% |
Enzo Biochem, Inc. (ENZ) Average ROE
How has ENZ ROE performed in the past?
The current ROE of Enzo Biochem, Inc. (ENZ) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-20.69%
5-year avg
-23.03%
10-year avg
-20.03%
Enzo Biochem, Inc. (ENZ) ROE vs. Peers
How is ENZ’s ROE compared to its peers?
Enzo Biochem, Inc.’s ROE is less than FONAR Corporation (5.78%), greater than Burning Rock Biotech Limited (-74.92%), greater than Sera Prognostics, Inc. (-51.73%), greater than Olink Holding AB (publ) (-7.07%), greater than LumiraDx Limited (-1557.76%), less than Genetron Holdings Limited (0%), greater than Psychemedics Corporation (-49.63%), greater than DarioHealth Corp. (-11.69%), less than Castle Biosciences, Inc. (1.47%), greater than Exagen Inc. (-92.58%), greater than Biodesix, Inc. (-277.36%), greater than Neuronetics, Inc. (-160.79%), less than Sotera Health Company (16.02%),
| Company | ROE | Market cap |
|---|---|---|
| 5.78% | $103.11M | |
| -74.92% | $54.55M | |
| -51.73% | $214.54M | |
| -7.07% | $3.24B | |
| -1557.76% | $0 | |
| 0% | $127.29M | |
| -49.63% | $13.76M | |
| -11.69% | $28.80M | |
| 1.47% | $834.90M | |
| -92.58% | $72.31M | |
| -277.36% | $186.20M | |
| -160.79% | $26.86M | |
| 16.02% | $3.63B |
Build a custom stock screener for Enzo Biochem, Inc. (ENZ) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Enzo Biochem, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Enzo Biochem, Inc. (ENZ) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Enzo Biochem, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Enzo Biochem, Inc.'s ROE?
How is the ROE calculated for Enzo Biochem, Inc. (ENZ)?
What is the highest ROE for Enzo Biochem, Inc. (ENZ)?
What is the 3-year average ROE for Enzo Biochem, Inc. (ENZ)?
What is the 5-year average ROE for Enzo Biochem, Inc. (ENZ)?
How does the current ROE for Enzo Biochem, Inc. (ENZ) compare to its historical average?